[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Crigler-Najjar Syndrome Drug Market Report 2018

January 2018 | 97 pages | ID: U4528599570EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Crigler-Najjar Syndrome Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Crigler-Najjar Syndrome Drug in these regions, from 2013 to 2025 (forecast).
United States Crigler-Najjar Syndrome Drug market competition by top manufacturers/players, with Crigler-Najjar Syndrome Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Audentes Therapeutics Inc
  • Genethon SA
  • International Stem Cell Corp
  • Promethera Biosciences SA
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • ALXN-1540
  • AT-342
  • HepaStem
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Crigler-Najjar Syndrome Drug Market Report 2018

1 CRIGLER-NAJJAR SYNDROME DRUG OVERVIEW

1.1 Product Overview and Scope of Crigler-Najjar Syndrome Drug
1.2 Classification of Crigler-Najjar Syndrome Drug by Product Category
  1.2.1 United States Crigler-Najjar Syndrome Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Crigler-Najjar Syndrome Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 ALXN-1540
  1.2.4 AT-342
  1.2.5 HepaStem
  1.2.6 Others
1.3 United States Crigler-Najjar Syndrome Drug Market by Application/End Users
  1.3.1 United States Crigler-Najjar Syndrome Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Crigler-Najjar Syndrome Drug Market by Region
  1.4.1 United States Crigler-Najjar Syndrome Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Crigler-Najjar Syndrome Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Crigler-Najjar Syndrome Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Crigler-Najjar Syndrome Drug Status and Prospect (2013-2025)
  1.4.5 New England Crigler-Najjar Syndrome Drug Status and Prospect (2013-2025)
  1.4.6 The South Crigler-Najjar Syndrome Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Crigler-Najjar Syndrome Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Crigler-Najjar Syndrome Drug (2013-2025)
  1.5.1 United States Crigler-Najjar Syndrome Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Crigler-Najjar Syndrome Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES CRIGLER-NAJJAR SYNDROME DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Crigler-Najjar Syndrome Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Crigler-Najjar Syndrome Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Crigler-Najjar Syndrome Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Crigler-Najjar Syndrome Drug Market Competitive Situation and Trends
  2.4.1 United States Crigler-Najjar Syndrome Drug Market Concentration Rate
  2.4.2 United States Crigler-Najjar Syndrome Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Crigler-Najjar Syndrome Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CRIGLER-NAJJAR SYNDROME DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Crigler-Najjar Syndrome Drug Sales and Market Share by Region (2013-2018)
3.2 United States Crigler-Najjar Syndrome Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Crigler-Najjar Syndrome Drug Price by Region (2013-2018)

4 UNITED STATES CRIGLER-NAJJAR SYNDROME DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Crigler-Najjar Syndrome Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Crigler-Najjar Syndrome Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Crigler-Najjar Syndrome Drug Price by Type (2013-2018)
4.4 United States Crigler-Najjar Syndrome Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES CRIGLER-NAJJAR SYNDROME DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Crigler-Najjar Syndrome Drug Sales and Market Share by Application (2013-2018)
5.2 United States Crigler-Najjar Syndrome Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES CRIGLER-NAJJAR SYNDROME DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Audentes Therapeutics Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Crigler-Najjar Syndrome Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Genethon SA
  6.2.2 Crigler-Najjar Syndrome Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Genethon SA Crigler-Najjar Syndrome Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 International Stem Cell Corp
  6.3.2 Crigler-Najjar Syndrome Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Promethera Biosciences SA
  6.4.2 Crigler-Najjar Syndrome Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview

7 CRIGLER-NAJJAR SYNDROME DRUG MANUFACTURING COST ANALYSIS

7.1 Crigler-Najjar Syndrome Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Crigler-Najjar Syndrome Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Crigler-Najjar Syndrome Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Crigler-Najjar Syndrome Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CRIGLER-NAJJAR SYNDROME DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Crigler-Najjar Syndrome Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Crigler-Najjar Syndrome Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Crigler-Najjar Syndrome Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Crigler-Najjar Syndrome Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Crigler-Najjar Syndrome Drug
Figure United States Crigler-Najjar Syndrome Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Crigler-Najjar Syndrome Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure ALXN-1540 Product Picture
Figure AT-342 Product Picture
Figure HepaStem Product Picture
Figure Others Product Picture
Figure United States Crigler-Najjar Syndrome Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Crigler-Najjar Syndrome Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Crigler-Najjar Syndrome Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Crigler-Najjar Syndrome Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Crigler-Najjar Syndrome Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Crigler-Najjar Syndrome Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Crigler-Najjar Syndrome Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Crigler-Najjar Syndrome Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Crigler-Najjar Syndrome Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Crigler-Najjar Syndrome Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Crigler-Najjar Syndrome Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Crigler-Najjar Syndrome Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Crigler-Najjar Syndrome Drug Sales Share by Players/Suppliers
Figure 2017 United States Crigler-Najjar Syndrome Drug Sales Share by Players/Suppliers
Figure United States Crigler-Najjar Syndrome Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Crigler-Najjar Syndrome Drug Revenue Share by Players/Suppliers
Figure 2017 United States Crigler-Najjar Syndrome Drug Revenue Share by Players/Suppliers
Table United States Market Crigler-Najjar Syndrome Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Crigler-Najjar Syndrome Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Crigler-Najjar Syndrome Drug Market Share of Top 3 Players/Suppliers
Figure United States Crigler-Najjar Syndrome Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Crigler-Najjar Syndrome Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Crigler-Najjar Syndrome Drug Product Category
Table United States Crigler-Najjar Syndrome Drug Sales (K Pcs) by Region (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Sales Share by Region (2013-2018)
Figure United States Crigler-Najjar Syndrome Drug Sales Share by Region (2013-2018)
Figure United States Crigler-Najjar Syndrome Drug Sales Market Share by Region in 2017
Table United States Crigler-Najjar Syndrome Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Revenue Share by Region (2013-2018)
Figure United States Crigler-Najjar Syndrome Drug Revenue Market Share by Region (2013-2018)
Figure United States Crigler-Najjar Syndrome Drug Revenue Market Share by Region in 2017
Table United States Crigler-Najjar Syndrome Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Sales Share by Type (2013-2018)
Figure United States Crigler-Najjar Syndrome Drug Sales Share by Type (2013-2018)
Figure United States Crigler-Najjar Syndrome Drug Sales Market Share by Type in 2017
Table United States Crigler-Najjar Syndrome Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Crigler-Najjar Syndrome Drug by Type (2013-2018)
Figure Revenue Market Share of Crigler-Najjar Syndrome Drug by Type in 2017
Table United States Crigler-Najjar Syndrome Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Crigler-Najjar Syndrome Drug Sales Growth Rate by Type (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Sales (K Pcs) by Application (2013-2018)
Table United States Crigler-Najjar Syndrome Drug Sales Market Share by Application (2013-2018)
Figure United States Crigler-Najjar Syndrome Drug Sales Market Share by Application (2013-2018)
Figure United States Crigler-Najjar Syndrome Drug Sales Market Share by Application in 2017
Table United States Crigler-Najjar Syndrome Drug Sales Growth Rate by Application (2013-2018)
Figure United States Crigler-Najjar Syndrome Drug Sales Growth Rate by Application (2013-2018)
Table Audentes Therapeutics Inc Basic Information List
Table Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales Growth Rate (2013-2018)
Figure Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales Market Share in United States (2013-2018)
Figure Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Revenue Market Share in United States (2013-2018)
Table Genethon SA Basic Information List
Table Genethon SA Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genethon SA Crigler-Najjar Syndrome Drug Sales Growth Rate (2013-2018)
Figure Genethon SA Crigler-Najjar Syndrome Drug Sales Market Share in United States (2013-2018)
Figure Genethon SA Crigler-Najjar Syndrome Drug Revenue Market Share in United States (2013-2018)
Table International Stem Cell Corp Basic Information List
Table International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales Growth Rate (2013-2018)
Figure International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales Market Share in United States (2013-2018)
Figure International Stem Cell Corp Crigler-Najjar Syndrome Drug Revenue Market Share in United States (2013-2018)
Table Promethera Biosciences SA Basic Information List
Table Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales Growth Rate (2013-2018)
Figure Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales Market Share in United States (2013-2018)
Figure Promethera Biosciences SA Crigler-Najjar Syndrome Drug Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Crigler-Najjar Syndrome Drug
Figure Manufacturing Process Analysis of Crigler-Najjar Syndrome Drug
Figure Crigler-Najjar Syndrome Drug Industrial Chain Analysis
Table Raw Materials Sources of Crigler-Najjar Syndrome Drug Major Players/Suppliers in 2017
Table Major Buyers of Crigler-Najjar Syndrome Drug
Table Distributors/Traders List
Figure United States Crigler-Najjar Syndrome Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Crigler-Najjar Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Crigler-Najjar Syndrome Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Crigler-Najjar Syndrome Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Crigler-Najjar Syndrome Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Crigler-Najjar Syndrome Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Crigler-Najjar Syndrome Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Crigler-Najjar Syndrome Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Crigler-Najjar Syndrome Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Crigler-Najjar Syndrome Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Crigler-Najjar Syndrome Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Crigler-Najjar Syndrome Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Crigler-Najjar Syndrome Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories